CIK 0001101026
- Non-accelerated filer
- Smaller reporting company
Zivo Bioscience, Inc.
Sign in to watch- Ticker
- ZIVO
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870699977
- Phone
- +1 248-452-9866
- Business address
- 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
- 4 Open-market buy 10% owner bought 50,600 shares at an average $0.24 ($12,106)
- 4 Open-market buy 10% owner bought 87,500 shares at an average $0.27 ($23,519)
- 4 Open-market buy 10% owner bought 201,125 shares at an average $0.26 ($51,396)
- 4 Open-market buy 10% owner bought 16,000 shares at $0.25 ($4,016)
- 4 Open-market buy 10% owner bought 18,500 shares at $0.25 ($4,562)
- 4 Open-market buy 10% owner bought 52,500 shares at $0.26 ($13,855)
- 4 Open-market buy 10% owner bought 60,000 shares at $0.26 ($15,744)
- 4 Open-market buy 10% owner bought 37,500 shares at $0.28 ($10,680)
- 4 Open-market buy 10% owner bought 163,000 shares at an average $0.27 ($44,622)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President/CEO bought 5,000 shares at $0.11 ($542)
- 4 Open-market buy President/CEO bought 95,000 shares at $0.11 ($10,289)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President, CEO acquired 1,458,232 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 10 of 12 · 239 filings